Q&A: American Cancer Society’s risk tool offers a ‘focus on action’

ORLANDO — A web-based cancer risk assessment tool offers users personalized resources and guidance for addressing modifiable risk factors while aligning with the core pillars of lifestyle medicine, according to a speaker.
Data on CancerRisk360 — developed by the American Cancer Society (ACS) — presented at the American College of Lifestyle Medicine’s annual meeting show the tool was well received by people during its first year of existence.
CancerRisk360 also produced between 621 to 1,351 outlink visits to webpages on cancer.org, including those on diet and physical activity, genetic testing,

Median age of HIV population projected to soar

The median age of people with HIV in the United States is expected to rise dramatically in the next 14 years, according to an analytic modeling study from Johns Hopkins University.
The study found the median age will climb to 61 years by 2040 — up from 51 years in 2025 — with 46% of the population aged older than 65 years.
Consequently, this aging shift will require “a higher demand” for the Ryan White HIV/AIDS Program and other federally funded programs, researchers said in the study, noting that people with HIV experience an increased risk for age-related comorbidities including

Consider hormone therapy to improve menopause-related skin changes

SAN DIEGO — Perimenopause and menopause can profoundly impact a woman’s skin and self-confidence and dermatologists must understand these hormonal shifts before starting any treatment, according to a speaker.
Menopausal women often experience a wide range of systemic symptoms including hot flashes, night sweats, insomnia, mood swings and skin changes. The transition period, known as perimenopause, lasts for approximately 4 to 8 years and can include similar symptoms, Sabrina G. Fabi, MD, FAAD, volunteer assistant clinical professor at Cosmetic Laser Dermatology in San Diego, said during a

Concerns rise over copay assistance program funding in retina

NEW YORK — To address gaps in access to retinal therapies, ophthalmologists must encourage companies to support underfunded copay assistance programs, while industry must work with policymakers to improve options for patients.
According to a presentation at OSN New York Retina, a 2025 survey of 455 members of the American Society of Retina Specialists found that 99% were concerned about the patient impact of underfunded copay assistance programs. Additionally, 94% reported a disruption in care caused by underfunding.
“Based on prior studies, we know that increasing patient copays can affect

Device shows benefit in severe tricuspid regurgitation

Transcatheter tricuspid valve repair improved health status and reduced tricuspid regurgitation severity vs. optimal medical therapy alone in patients with symptomatic severe tricuspid regurgitation, a speaker reported.
Mortality and heart failure hospitalizations did not differ significantly, but the CLASP II TR trial was not powered for mortality, according to results presented at TCT 2026.
As Healio previously reported, the FDA approved the system (Pascal Precision, Edwards Lifesciences) for patients at elevated surgical risk with symptomatic severe tricuspid regurgitation despite optimal

‘Give back to yourself’: Flourishing as a provider

ORLANDO — Self-care can help healthcare providers truly flourish, according to a speaker here.
In her keynote presentation at the annual ACLM conference, Dawn Mussallem, DO, DipABLM, chief medical officer of Fountain Life in Jacksonville, Florida, discussed the importance of a healthcare provider’s vitality both for themselves and their patients.
Although flourishing is something that providers “aren’t very good [at] in our own lives,” Mussallem said that, if their own self-care is neglected, providers can carry exhaustion into the exam room with them.
In 2023, 45.2% of physicians reported

Speaker: Cybersecurity becoming important aspect of AI governance

ORLANDO — Cybersecurity has become a critical component of AI governance, according to a speaker at AIMed26.
Dennis Chornenky, founder and CEO of DomeLabs, discussed how the rapid evolution of AI is correlated to an increasing need for cybersecurity awareness and control.
“When AI governance is narrowly defined as a compliance checklist, cybersecurity and value realization remain siloed, creating critical gaps where the greatest risks often emerge,” Chornenky told Healio. “Today’s rapidly evolving AI landscape demands an integrated approach to governing, securing

Asking the right questions: How to design fairer, more rigorous observational studies

Observational studies remain a valuable way to assess real-world relationships and long-term outcomes, but confounding variables, selection bias and poor design can make for spurious associations that perpetuate misinformation.
The most difficult step for researchers designing an observational study is not choosing a statistical method, Nandita Mitra, PhD, professor of biostatistics and codirector of the Center for Causal Inference at the Hospital of the University of Pennsylvania, said during a keynote presentation at the Dermatology in Pharma Educational Collaborative (DPEC).
Before analyzing

Deviations in brain atrophy linked to higher dementia risk

SAN DIEGO — People who experienced brain volume loss at a rate that deviated from others of similar peak brain size were more likely to progress from cognitively normal to mild cognitive impairment over 5 years, according to a poster presentation.
The rate of brain atrophy has different implications for people with different peak brain sizes, which complicates efforts by physicians to determine what level of atrophy warrants intervention, Jonadab dos Santos Silva, MD, PhD, a neurology resident with the Yale School of Medicine, said at the American Neurological Association’s 151st annual

FDA clears tubeless automated insulin delivery system

The FDA has cleared a tubeless cartridge and infusion set to be used with an automated insulin delivery system for people with diabetes, according to a press release from Tandem Diabetes Care.
The Tandem Mobi tubeless cartridge and infusion set will allow users to convert the current tubed Tandem Mobi insulin pump into a tubeless device. Tandem Mobi uses Control-IQ+ technology to predict glucose levels up to 30 minutes in the future and adjust insulin as needed using continuous glucose monitoring data. The system is compatible with smartphones using the device’s mobile app.
As Healio previously